Power Law company profile

Inversago Pharma

Biotech & Life Sciences · St-Eustache, Canada · Founded 2015 Unicorn

Specialized in the development of new therapies focusing on CB1 blockade, based on first-in-class, peripherally-acting, CB1 inverse agonists

Valuation

$1–2.5B

Latest valuation · 2026

Unlock exact value

Headcount

<100

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

12 investors on Inversago Pharma's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 7 investors entered at this stage

Accel-Rx Health Sciences Accelerator

JDRF T1D Fund

Anges Quebec

AQC Capital

Genesys Capital

Tarnagulla Ventures

Amorchem

Series B+ 5 investors entered at this stage

Forbion Capital Partners

Amgen Ventures

NEA

Fonds de solidarité FTQ

AdMare BioInnovations

Global footprint

Where Inversago Pharma has talent and traffic

Workforce by country

2 countries with
team presence

🇨🇦 Canada99.4%

🇺🇸 United States6.7%

2 countries shown

Web traffic by country

2.7K monthly visits
across markets

🇺🇸 United States48.1%

🇨🇦 Canada37%

🇮🇹 Italy7.4%

🇮🇳 India3.7%

🇹🇷 Turkey3.7%

Top 5 markets shown

Patent intelligence

$179k patent portfolio · 2 active families

Estimated portfolio value

$179k

0.02% of valuation · 915.1× smaller than top peer Amicus Therapeutics ($164M)

2 active patent families

Where Inversago Pharma innovates PharmacologyCannabinoid receptorDiseasePyrazolePharmaceutical drug

Where Inversago Pharma concentrates vs peers

Each axis is a top-10 topic across Inversago Pharma and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Inversago Pharma

An AI-synthesized read of the highest-engagement posts about Inversago Pharma on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Inversago Pharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles